Related Topics News -

     
 Title only   |   Print 
     
君實生物特瑞普利單抗聯合化療相關臨床達最終研究終點

2026-05-27T  
君實生物特瑞普利單抗注射液內地獲批第13項適應症

2026-05-22T  
《業績》君實生物首季虧損收窄至2,056萬人民幣

2026-04-27T  
《新股》邁威生物入場費6,203.95元 引山東國資委及藥明生物等基投

2026-04-20T  
《業績》君實生物全年虧損收窄至8.41億人民幣

2026-03-13T  
《港股》恆指收升551點 騰訊漲逾7% MiniMax炒高22%

2026-03-10T  
君實生物特瑞普利單抗注射液上市申請獲受理

2026-03-09T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.